Latest news
Increased dose of Eylea to extend treatment intervals
Posted: Friday 1 March 2024
Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.
Find out more
Encouraging results from light therapy study for dry AMD
Posted: Friday 1 March 2024
Early results from a study assessing the effectiveness of the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD), have shown promise.
Find out more
Patients reveal communication gaps in diagnosis
Posted: Monday 5 February 2024
Patients have highlighted noticeable gaps in communication when they are first diagnosed with macular disease, or if they are considered at risk of developing the condition.
Find out more
Another new drug offers hope for Stargardt patients
Posted: Monday 29 January 2024
Another drug to potentially treat Stargardt has shown positive results in slowing down the progression of the disease in a recent trial.
Find out more
‘We’re hoping our research can lead to potential treatments’
Posted: Wednesday 20 December 2023
A groundbreaking research project is underway, focusing on screening a library of already licensed drugs to potentially treat Stargardt disease.
Find out more
World Geographic Atrophy Day raises awareness of common condition
Posted: Tuesday 5 December 2023
The first-ever World Geographic Atrophy Day raises awareness of the condition and the five million people living with it across the globe.
Find out more
Macular disease under the spotlight at Conservative conference
Posted: Wednesday 25 October 2023
The Macular Society's director of research took to the stage at the Conservative Party Conference earlier this month to shine a light on the need to improve healthcare, especially for people living with macular disease.
Find out more
Are we a step closer to treating AMD with red light?
Posted: Thursday 28 September 2023
Red light has been shown to improve declining eyesight, with one particular study showing promise for patients diagnosed with dry age-related macular degeneration (AMD).
Find out more
Volunteers needed to test home monitoring app
Posted: Thursday 7 September 2023
Digital health company, OKKO Health, is calling for more volunteers to help test a new app which could revolutionise eye care for people living with macular disease.
Find out more
Is blue light damaging and are filters worth it?
Posted: Friday 1 September 2023
We often get asked whether blue light is dangerous to the macula and whether blue light filtering glasses are worth getting. Recent research has shown that blue light filters often do not live up to the claims they make.
Find out more
Second drug for dry AMD becomes available in the US
Posted: Tuesday 8 August 2023
Another new drug to treat late-stage dry age-related macular degeneration (AMD) has been approved for use in the US.
Find out more
Macular Society supports Edge Hill University's groundbreaking AMD research
Posted: Friday 7 July 2023
Macular Society Trustees have visited Edge Hill University’s labs to talk to its world-leading researchers on age-related macular degeneration (AMD).
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter
